Participating Clinical Centers
|
Penn State - Milton S Hershey Medical Center |
The H. Lee Moffitt Cancer Center and Research Institute
Contact Information:
Alan List, M.D.
H. Lee Moffitt Cancer Center
Malignant Hematology Program
Office: 813.745.8090
Email: listaf@moffitt.usf.edu
P.K. Epling-Burnette, Ph.D.
Research Assistant Professor
Office: 813.972.2000 ext. 7443
Fax: 813.972.7623
Email: burnetpk@moffitt.usf.edu
Nurse Coordinator
Denise Cosgrove, RN, BSN, OCN
Hematologic Malignancies Program
Office: 813.979.3058
Fax: 813.979.6732
About Us
The H. Lee Moffitt Cancer Center and Research Institute at The University of South Florida in Tampa is a National Cancer Institute-designated Comprehensive Cancer Center serving among the largest patient volumes in the country. Within the Bone Marrow Failure Research Consortium, the Moffitt Cancer Center serves as the primary data registry center and a major clinical investigation site. Faculty members of the Hematologic Malignancies Program at Moffitt are divided by disease interest groups to include Lymphoma, Myeloma and Leukemia. Our Leukemia Group physicians specialize in laboratory and clinical investigations of marrow based malignancies and Bone Marrow Failure Syndromes. Dr. Alan List is the Program Leader for the Hematologic Malignancies Program. Scientists such as P.K. Burnette characterize the immunologic regulation of bone marrow failure and opportunities for new therapeutic development.
Our Team:
| Contributing Physician: | Area Of Expertise |
|---|---|
| Alan List, MD | MDS, AA |
| Hussein Saba, MD, PhD | AA, MDS, PNH |
| Lubomir Sokol, MD, PhD | LGL Leukemia, AA |
| Jeffery Lancet, MD | AML, ALL, PNH, MDS, Myelofibrosis |
| Gregoire Bergier, MD | AA, LGL Leukemia |
| Bhavesh Balar | AA, MDS, AML |
| Kapil Bhalla, MD, PhD | CML, Myeloproliferative |
| Kenneth Zuckerman, MD | AML, Myeloproliferative Disorders |
| Claudio Anasetti, MD | Stem Cell Transplantation |
Links of Interest:
The H. Lee Moffitt Cancer Center and Research Institute Web Site
01.05.06 - Tampa Tribune: "Patients, Moffitt See New Drug's Benefit" by Carol Gentry
Current Clinical Trials:
Publications:
